Skip to main content
Log in

Who Benefits from Portal Vein Resection during Pancreaticoduodenectomy for Pancreatic Cancer?

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract.

Portal vein resection during pancreaticoduodenectomy has recently experienced renewed interest. We describe our results with this procedure over a 20-year period. Among 88 consecutive pancreatectomies for cancer of head of the pancreas, 14 included en bloc removal of the portal vein. There was no hospital mortality. Only 21% were found to have histologically confirmed cancer invasion, and the remainder had inflammatory adherence. Two-year survival was 15% compared to 34% for patients who did not have portal vein resection. There were no 5-year survivors. We discuss our results in light of other recent reports.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Launois, B., Stasik, C., Bardaxoglou, E. et al. Who Benefits from Portal Vein Resection during Pancreaticoduodenectomy for Pancreatic Cancer?. World J. Surg. 23, 926–929 (1999). https://doi.org/10.1007/s002689900601

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002689900601

Keywords

Navigation